Hydrogen sulfide: Recent development of its dual donors and hybrid drugs

Author:

Xu Shi1,Shieh Meg1ORCID,Paul Bindu D.2345ORCID,Xian Ming1

Affiliation:

1. Department of Chemistry Brown University Providence Rhode Island USA

2. Department of Pharmacology and Molecular Sciences The Johns Hopkins University School of Medicine Baltimore Maryland USA

3. Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA

4. The Solomon H. Snyder Department of Neuroscience Johns Hopkins University School of Medicine Baltimore Maryland USA

5. Lieber Institute for Brain Development Baltimore Maryland USA

Abstract

AbstractHydrogen sulfide (H2S) is an important gaseous signalling molecule known to be critically involved in regulating cellular redox homeostasis. As the beneficial and therapeutic effects of H2S in pathophysiology, such as in cardiovascular and neurodegenerative diseases, have emerged, so too has the drive for the development of H2S‐releasing compounds (aka donors) and their therapeutic applications. Most reported donor compounds singularly release H2S through biocompatible triggers. An emerging area in the field is the development of compounds that can co‐deliver H2S with other drugs or biologically relevant species, such as reactive oxygen and nitrogen species (ROS and RNS, respectively). These H2S‐based dual donors and hybrid drugs are expected to offset negative side effects from individual treatments or achieve synergistic effects rendering them more clinically effective. Additionally, considering that molecules exist and interact physiologically, dual donors may more accurately mimic biological systems as compared to single donors and allow for the elucidation of fundamental chemistry and biology. This review focuses on the recent advances in the development of H2S‐based dual donors and hybrid drugs along with their design principles and synergistic effects.

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3